Peters, S., Dziadziuszko, R., Kalinka, E., Gazzah, A., Cousin, S., Garcia, M. E. O., Vicente, D., Johnson, T. T., Yoshida, T., Ma, Y., Dorleacq, N., Yang, D., Leal, T. (2026). DAREON-8: Updated efficacy and safety from a phase I dose-escalation/expansion trial of first-line (1L) obrixtamig plus chemotherapy and atezolizumab in extensive-stage small cell lung carcinoma (ES-SCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8089